LIVE POLIO IRUS VACCINES

630 Index
T marker-continued
T- strains in wild viruses, 66
technique, 5, 117, 125
valuable adjunct to IST, 56
Tadzhik SSR
programs, 419, 582
Taranova, G. P., paper 240-265; 418
Tashkent, Uzbek SSR
immunization during epidemic, 421-422, 429
laboratory diagnosis substantiated, 420
Tataki village, Japan
Type 1 polio epidemic 1956, 191
Temperature
effect of small variations, 190
effect of RNA production of cold variant, 63
type of equipment specified, 132
Temperature marker, see T marker
Teratogenic effects
none attributable to vaccine, 215
produced during pregnancy by live vaccine, 215
risk to fetus, 213
Terramycin
enteritis prevention, 68
Tetanus antigen
with polio, response of infants, 328
Thermal sensitivity tests
see T marker
Thoracic duct
pathway of infection plotted, 7
Throat
inhibition of virus at low antibody levels, 206
swabs for virus isolation, 358
Tin anniversary
of live vaccine, 5-9
Tissue culture
characteristics before and after gastrointestinal
passage, 124-131
fecal sample examination, 377
instability of strains after passage, 28, 600
interference between two viruses, 203
maintenance medium, 359
passage to increase inoculum, 133
relationship to reproductive capacity in intestinal
tract, 108
vaccine test, 505
Tissue culture doses
related to effective doses, 50
Tissue culture markers, see also d, T, t, ref, MS, etc.
choice of systems, 5
CNS isolates showed alterations, 76
T marker, method of choice, 58
test genetic stability of vaccine, 13
TN
see Vaccine, Attenuated, Type 2. TN (Koprowski)
Tobin, John O'Hara. 597-598
Tokyo, 198
Tolerance study
in infections with no antibody produlction, 328
Tolskaya, E. A., paper 240-265: 413-428
Toluca, Mexico, 385, 401
enteric viruses isolation techniques, 591
field trial, 377-385
polio isolations dropped 11%, 410
Tonsillar fauces
vaccination with cotton swab, 315
Tonsillectomy
recovery of virus in patient, 350
vaccination contraindicated, 597
Topley and Webster
experimental epidemiology in mice, 174, 578
Transplacental antibodies, see Antibodies, maternal
Trichuris trichuria
Cuban children infested, 368
Tri-immunol
injected IM into gluteus, 98
Tristan da Cunha
trial, 475
Tumor-inducing agent
and vaccine, 329
Turkmenst SSR
no vaccination program, 581
two vaccinations planned, 1960, 419
Typhus
subjects sensitized by instufficient antigen, 374
Ukhtomsk, USSR, 242
Ukrainian SSR
three programs, 1960, 419, 582
Umbilical cord
blood specimens, 287
Union of South Africa, see South Africa, Union of
United States
epidemics despite Salk vaccinations, 576, 579
isolates serologically identical with CHAT, 66
paralytic polio rate and Salk vaccine experience,
599
Sabin vaccine tested, 580
United States Public Health Service
Communicable Disease Center, 436, 438, 448, 569
licensing requirements for product, 595
Urticaria, see Reactions
Uspensky, Y. S., paper 413-428
USSR, see Soviet Union
Ustí, Czechoslovakia
vaccination program, 507
Uzbek SSR, see also Tashkent
two programs, 1960, 419, 582
Vaccination
and polio incidence, 429
and spread in families widely scattered, 145
booster optimum time, 214
campaign management, 486, 522, 526, 582. 584, 594
compulsory, 497
during epidemic, 574
effect of breast feeding, 324
effect of seasonal changes, 411, 493, 535, 578
epidemiological and virological follow-tup, 134-142
hospital volunteers, Japan, 193
infants, 226, 270, 294-301
influence of maternal antibodies, 294-295
interference from enteroviruses, 377-385, 585
intervals between vaccination and illness, 469, 571
massive scale, 600
pregnant women and young infants, 207-227